Æsculapius Farmaceutici Overview

  • Year Founded
  • 1959

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 77

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Æsculapius Farmaceutici General Information

Description

Developer and seller of pharmaceutical products based in Brescia, Italy. The company's products include medical devices, supplements, anti-inflammatory drugs, tonics, dermatological, probiotics and cardio vascular drugs, thereby providing its customers with quality products, which combine the therapeutic efficacy to the maximum safety and compliance.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Via Cefalonia, 70
  • C/O Crystal Palace 13° Floor
  • 25124 Brescia(Brescia)
  • Italy
+39 030
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Distributors/Wholesale
Other Devices and Supplies
Parent Company
Corporate Office
  • Via Cefalonia, 70
  • C/O Crystal Palace 13° Floor
  • 25124 Brescia(Brescia)
  • Italy
+39 030

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Æsculapius Farmaceutici Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Æsculapius Farmaceutici‘s full profile, request access.

Request a free trial

Æsculapius Farmaceutici Patents

Æsculapius Farmaceutici Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-0894794-A1 Optical isomers of cloperastine Inactive 31-Jul-1997
CA-2086440-A1 Eseroline derivatives having anticholinesterase activity, a process for their preparation and pharmaceutical compositions containing them Inactive 31-Dec-1991
EP-0550007-A2 Eseroline derivatives having anticholinesterase activity, a process for their preparation and pharmaceutical compositions containing them Inactive 31-Dec-1991
EP-0550007-A3 Eseroline derivatives having anticholinesterase activity, a process for their preparation and pharmaceutical compositions containing them Inactive 31-Dec-1991
US-2649359-A Device for dosing urea in blood and in urine Inactive 30-Sep-1950 G01N33/48742
To view Æsculapius Farmaceutici’s complete patent history, request access »

Æsculapius Farmaceutici Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Æsculapius Farmaceutici FAQs

  • When was Æsculapius Farmaceutici founded?

    Æsculapius Farmaceutici was founded in 1959.

  • Where is Æsculapius Farmaceutici headquartered?

    Æsculapius Farmaceutici is headquartered in Brescia, Italy.

  • What is the size of Æsculapius Farmaceutici?

    Æsculapius Farmaceutici has 77 total employees.

  • What industry is Æsculapius Farmaceutici in?

    Æsculapius Farmaceutici’s primary industry is Pharmaceuticals.

  • Is Æsculapius Farmaceutici a private or public company?

    Æsculapius Farmaceutici is a Private company.

  • What is Æsculapius Farmaceutici’s current revenue?

    The current revenue for Æsculapius Farmaceutici is .

  • When was Æsculapius Farmaceutici acquired?

    Æsculapius Farmaceutici was acquired on 15-Dec-2023.

  • Who acquired Æsculapius Farmaceutici?

    Æsculapius Farmaceutici was acquired by Ceres Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »